| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/11/2007 | WO2006044049A3 Method of providing customized drug delivery systems |
| 01/11/2007 | WO2006041592A3 Large-scale manufacturing process for the production of pharmaceutical compositions |
| 01/11/2007 | WO2006032420A3 Method for comminuting mechanically agglomerated pigments and pharmaceutically active substances |
| 01/11/2007 | WO2005099665A3 Imroved formulations of 6-mercaptopurine |
| 01/11/2007 | US20070010799 Patch stabilization of rods for treatment of cardiac muscle |
| 01/11/2007 | US20070010577 Administering an emulsion of a nanoparticulate carrier containing an alpha v beta 3 integrin targeting ligand and fumagillin, TNP 470 or rapamycin that are coupled through colocalization in the nanoparticles; the antiangiogenic agent is effective at a dosage at least 56,000 fold lower than the free drug |
| 01/11/2007 | US20070010575 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/11/2007 | US20070010570 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 01/11/2007 | US20070010502 Synergistic mixture containing pyrimidopyrimidine compound with another active material |
| 01/11/2007 | US20070010474 NF-kappaB oligonucleotide decoy molecules |
| 01/11/2007 | US20070010464 Avermectin and praziquantel combination therapy |
| 01/11/2007 | US20070010425 Pharmaceutical compositions and methods for insulin treatment |
| 01/11/2007 | US20070010422 Improved bioavailability; for oral and intracolonic administration |
| 01/11/2007 | US20070009951 Gene expression vaccine |
| 01/11/2007 | US20070009611 Treatment of wounds and compositions employed |
| 01/11/2007 | US20070009606 Manufacturing process, such as three dimensional printing, including binding of water-soluble material followed by softening and flowing and forming films of organic-solvent-soluble material |
| 01/11/2007 | US20070009605 Encapsulation of water soluble peptides |
| 01/11/2007 | US20070009604 Such as proteins or polypeptides via anti-solvent under supercritical conditions; water solubility; Rapid Expansion of Supercritical Solutions or Gas Anti-solvent precipitation |
| 01/11/2007 | US20070009603 Compositions comprising fenofibrate and atorvastatin |
| 01/11/2007 | US20070009602 Direct drug delivery system based on thermally responsive biopolymers |
| 01/11/2007 | US20070009601 Composition and method for the treatment of water related ear disorders |
| 01/11/2007 | US20070009600 Antidepressant dosage form |
| 01/11/2007 | US20070009599 Asymmetrically coated table |
| 01/11/2007 | US20070009598 Sustained-release microgranules containging gingko biloba extract and the process for manufacturing these |
| 01/11/2007 | US20070009597 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 01/11/2007 | US20070009596 Controlled drug release composition resistant to in vivo mechanic stress |
| 01/11/2007 | US20070009595 Sugar alcohol composition for tableting |
| 01/11/2007 | US20070009594 Compositions and methods for treatment of cycle-related symptoms |
| 01/11/2007 | US20070009593 Methods of treating cancer |
| 01/11/2007 | US20070009592 Immediate release pharmaceutical granule compositions and a continuous process for making them |
| 01/11/2007 | US20070009591 ACE inhibitor formulation |
| 01/11/2007 | US20070009590 Physiologically active composition based on phosphatidylserine |
| 01/11/2007 | US20070009589 Extended release compositions |
| 01/11/2007 | US20070009588 comprises fentanyl as active ingredient, pressure-sensitive adhesive base, and tackifier resin; pressure-sensitive adhesive base comprising polyisobutylene and styrene/isoprene/styrene block copolymer; easily produced, has long-term continuity, and is excellent in adhesion and conformability to skin |
| 01/11/2007 | US20070009583 comprises absorber materials and proteolytic enzymes contained in liposomes, for debridement of necrotic and non-viable tissues in injuries, by controlled or sustained release of proteolytic enzymes to the injury |
| 01/11/2007 | US20070009581 Multicomponent material comprising chitosan |
| 01/11/2007 | US20070009580 Non-adhesive hydrogels |
| 01/11/2007 | US20070009579 Polysaccharide pseudo-sponge |
| 01/11/2007 | US20070009578 Haemostatic composition comprising hyaluronic acid |
| 01/11/2007 | US20070009567 Methods and compositions for the treatment and prevention of staphylococcal infections |
| 01/11/2007 | US20070009564 Drug/polymer composite materials and methods of making the same |
| 01/11/2007 | US20070009559 Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same |
| 01/11/2007 | US20070009558 Sugar-free storage-stable antihistaminic syrups |
| 01/11/2007 | US20070009557 Moldable implant material |
| 01/11/2007 | US20070009490 drug delivery devices comprising multicompartments containing dry nonpathogenic bacterial strains, used for treating gastrointestinal disorders |
| 01/11/2007 | US20070009487 Minimal promoters and uses thereof |
| 01/11/2007 | US20070009482 Stimulant of immunology response; viricides |
| 01/11/2007 | US20070009445 Aerosol compositions and methods |
| 01/11/2007 | US20070009444 Method for preparing powder exhibiting low susceptibility to electrification |
| 01/11/2007 | US20070009441 Biodegradable nanoparticles |
| 01/11/2007 | DE4342092B4 Langwirkende Injektionssuspension und Verfahren zur Herstellung Long-acting injection suspension and process for producing |
| 01/11/2007 | DE10246377B4 Verfahren zur Herstellung von Pflastersystemen mit dotierten Trägermaterialien als Reservoir A process for the production of paving systems with doped support materials as a reservoir |
| 01/11/2007 | DE102005032236A1 Verfahren zur Beschichtung dimensionsstabiler Partikel mit feinteiligen, dimensionsstabilen Partikeln A method for coating of dimensionally stable particles with finely divided, dimensionally stable particles |
| 01/11/2007 | DE10137876B4 Behandelte wasserunlösliche Feststoffteilchen, ihre Herstellung und Verwendung Treated water-insoluble solid particles, their preparation and use |
| 01/11/2007 | CA2614347A1 Pharmaceutical composition comprising simvastatin and ezetimibe |
| 01/11/2007 | CA2614089A1 Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| 01/11/2007 | CA2612864A1 Composition and dosage form comprising a solid or semi-solid matrix |
| 01/11/2007 | CA2611125A1 Prolonged release formulation of active principles having a ph-dependent solubility |
| 01/10/2007 | EP1741704A1 Method for increasing specific surface area of slightly soluble drug |
| 01/10/2007 | EP1741450A1 Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 01/10/2007 | EP1741448A1 Crosslinkable pressure-sensitive adhesive for the skin |
| 01/10/2007 | EP1741443A2 Combination meningitidis B/C vaccines |
| 01/10/2007 | EP1741439A1 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method |
| 01/10/2007 | EP1741438A1 Pharmaceutical preparation containing bacterial cell wall skeleton component |
| 01/10/2007 | EP1741435A1 Oral modified-release lozenges and their preparation method |
| 01/10/2007 | EP1741433A1 Pharmaceutical composition comprising an androgen |
| 01/10/2007 | EP1741427A1 Pharmaceutical composition comprising simvastatin and ezetimibe |
| 01/10/2007 | EP1741426A2 Melt-extruded orally administrable opioid formulations |
| 01/10/2007 | EP1741425A2 Novel antiviral pharmaceutical composition |
| 01/10/2007 | EP1741424A2 Solid pharmaceutical dispersions with enhanced bioavailabilty |
| 01/10/2007 | EP1741423A1 Drug depot for parenteral drug release, in particular intravascular drug release |
| 01/10/2007 | EP1740770A1 Treated crimped multi-ply product |
| 01/10/2007 | EP1740668A1 Adhesive for dermal patch and production process thereof |
| 01/10/2007 | EP1740599A1 Anthracycline derivatives |
| 01/10/2007 | EP1740240A2 Implant having mems flow module with movable, flow-controlling baffle |
| 01/10/2007 | EP1740236A2 Coating compositions for bioactive agents |
| 01/10/2007 | EP1740235A1 Coating compositions for bioactive agents |
| 01/10/2007 | EP1740214A2 Method of stabilizing disordered cefovecin sodium salt |
| 01/10/2007 | EP1740193A2 Macromolecule-containing sustained release intraocular implants and related methods |
| 01/10/2007 | EP1740189A1 Lung surfactant supplements |
| 01/10/2007 | EP1740188A1 Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
| 01/10/2007 | EP1740186A1 Biodegradable intraocular implants containing prostamides |
| 01/10/2007 | EP1740166A2 Therapeutic antimicrobial compositions and methods |
| 01/10/2007 | EP1740164A1 Statins for the treatment of ocular hypertension and glaucoma |
| 01/10/2007 | EP1740162A1 Topical methadone compositions and methods for using the same |
| 01/10/2007 | EP1740161A2 Transdermal system secured against misuse |
| 01/10/2007 | EP1740160A2 Controlled delivery of therapeutic agents from medical articles |
| 01/10/2007 | EP1740159A1 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens |
| 01/10/2007 | EP1740158A1 Pharmaceutical composition for topical use in form of xerogels or films and methods for production |
| 01/10/2007 | EP1740157A1 Anti-excitotoxic sustained release intraocular implants and related methods |
| 01/10/2007 | EP1740156A1 Method for the production of an abuse-proof, solid form of administration |
| 01/10/2007 | EP1740155A1 Polycylic thiazoles as potassium ion channel modulators |
| 01/10/2007 | EP1740154A1 Rapid acting drug delivery compositions |
| 01/10/2007 | EP1740153A1 Biodegradable ocular implants with long-term release characteristics |
| 01/10/2007 | EP1740120A2 Naltrexone long acting formulations and methods of use |
| 01/10/2007 | EP1572167A4 Transdermal buprenorphine dosage regimen for analgesia |
| 01/10/2007 | EP1416920B1 Multiplex drug delivery system suitable for oral administration |
| 01/10/2007 | EP1355632B1 Amlodipine free base |
| 01/10/2007 | EP1176984B1 Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates |
| 01/10/2007 | EP1054672B1 Morphine sulphate microgranules, method for making same and pharmaceutical preparations |